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 Joaquim M.  Oliveira ,  Giovanni  Abatangelo ,  and  Rui L.  Reis  In this study, the stability and biocompatibility of methacrylated gellan gum 
hydrogels, obtained either by ionic- (iGG-MA) or photo-crosslinking (phGG-
MA), were evaluated in vitro and in vivo. Size exclusion chromatography 
analysis of the methacrylated gellan gum (GG-MA) powder revealed that 
molecular weight is lower as compared to the non-modifi ed material, i.e., 
low acyl gellan gum. The water uptake and swelling of iGG-MA and phGG-
MA hydrogels were investigated in phosphate-buffered saline solution (pH 
7.4). The biocompatibility of the hydrogels was fi rstly evaluated by producing 
cell-laden hydrogels. The in vitro cells encapsulation study showed that lung 
fi broblast cells (L929 cells) and human intervertebral disc (hIVD) cells are 
viable when cultured within both hydrogels, up to 21 days of culturing. The 
iGG-MA and phGG-MA hydrogels were also subcutaneously implanted in 
Lewis rats for 10 and 18 days. Tissue response to the hydrogels implantation 
was determined by histological analysis (haematoxylin-eosin staining). A thin 
fi brous capsule was observed around the implanted hydrogels. No necrosis, 
calcifi cation, and acute infl ammatory reaction were observed. The results pre-
sented in this study demonstrate that iGG-MA and phGG-MA hydrogels are 
stable in vitro and in vivo, support L929 and hIVD cells’ encapsulation and 
viability, and were found to be well-tolerated and non-toxic in vivo.  1. Introduction 
 An intervertebral disc (IVD) is constituted by two structures, 
an outer multilayer fi ber structure (annulus fi brosus, AF) and 
a gel-like inner core (nucleus pulposus, NP), which are sand-
wiched in part between two cartilage endplates. [ 1 ] In a diseased © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
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namely: (i) biochemical composition 
changes, i.e., extracellular matrix (ECM) 
remodelling, (ii) loss of hydration of NP, 
(iii) decrease in disc height, (iv) deterioration 
of facet cartilage, and (v) disc protrusion or 
herniation. [ 2–4 ] Conservative approaches for 
treatment of degenerating IVD are mainly 
based on drug administration, [ 5 ] but severe 
disc problems often require surgical inter-
vention such as discectomy, spine fusion, 
and disc replacement. [ 6–8 ] 
 Pre-clinical research efforts are 
focused on developing new strategies to 
decrease progression and prevent some 
of the changes observed in a degenerating 
IVD. [ 9 , 10 ] With the advent of tissue engi-
neering, the use of stem cells and platelet-
rich plasma (PRP)-based strategies com-
prise new regenerative possibilities for 
treating IVD degeneration. [ 11–13 ] However, 
the use of cells or PRPs alone may not be 
feasible, mainly due to the short half-life 
of the GFs and the need to comply with 
fully restoration of IVD functionality (e.g., 
disc height). [ 6 ]  Hydrogels have attracted a great deal of attention as poten-
tial NP substitutes, because they allow irregular surgical defects 
to be completely fi lled using minimally invasive techniques. In 
addition, hydrogels also present the advantage of functionally 
mimicking the native ECM, supporting NP cells functions and 1wileyonlinelibrary.com
batangelo
gy
edical Technology
dova, Italy 
Surgery
ova, Italy 
www.MaterialsViews.com
FU
LL
 P
A
P
ER
www.advhealthmat.de
2sustaining the release of bioactive molecules. [ 14–18 ] Reza et al . [ 19 ] 
proposed the photo-crosslinked carboxymethyl-cellulose hydro-
gels as tunable biomaterials for NP cell encapsulation, although 
these lack the adequate mechanical properties. By its turn, Su 
et al . [ 20 ] reported on oxidized hyaluronic acid/adipic acid dihy-
drazide (oxi-HA/ADH) hydrogel formulations for NP regenera-
tion. The oxi-HA/ADH hydrogels changed from liquid form 
into a gel-like structure within few minutes, but low cellular 
viability was observed for certain oxi-HA/ADH hydrogel mix-
tures, in vitro . Moreover, the fast degradation of the hydrogels 
and poor long-term stability can compromise future application 
in NP tissue engineering strategies. 
 Our group [ 21 , 22 ] is a pioneer in processing hydrogels based 
on gellan gum (GG), which is a polysaccharide obtained from 
 Sphingomonas elodea , for several tissue engineering applications. 
The GG hydrogel gelation occurs by ionic-crosslinking with 
divalent cations. The GG hydrogel has been shown to effi ciently 
sustain the deliver and growth of human articular chondrocytes 
and support the deposition of a hyaline-like ECM, leading to the 
formation of a functional cartilage. [ 23 ] Although GG produces 
stable gels, the mechanical functionality and long-term stability 
of GG needs to be tuned, in order to fully comply with the 
IVD requirements, namely to be used as acellular and cellular 
NP substitutes. Recently, methacrylated gellan gum (GG-MA) 
hydrogels, the so-called ionic- (iGG-MA) and photo-crosslinked 
(phGG-MA) methacrylated gellan gum, were produced through 
chemical modifi cation by means of methacrylation of low acyl 
GG. [ 24 , 25 ] The main advantages of the GG-MA hydrogels as 
compared to others [ 19 , 20 , 22 , 25 ] are: (i) the possibility to control 
endothelial cells infi ltration and blood vessel ingrowth’s, [ 26 ] 
(ii) tunable and improved mechanical properties, and (iii)  in 
situ gelation, within seconds to few minutes. [ 24 , 25 ] In previous 
work, [ 25 ] the modifi ed material and the developed iGG-MA and 
phGG-MA hydrogels were extensively characterized in respect 
to its physicochemical properties. In particular, the mechanical 
behaviour of the iGG-MA and phGG-MA hydrogel discs was 
characterized by dynamic mechanical analysis (DMA). The 
storage modulus presented by the phGG-MA discs at 1 Hz 
was higher (122.8  ± 8.3 kPa) than that of GG hydrogels (56.2  ± 
1.4 kPa), while in the iGG-MA hydrogel discs an intermediate 
behaviour (89.5  ± 7.4 kPa) was observed. By performing GG 
methacrylation with different reaction conditions and using dif-
ferent crosslinking methods for hydrogel formation, it is pos-
sible to tune the crosslinking degree of the polymer, which then 
infl uences its mechanical properties, degradation profi le and 
swelling capacity. Moreover, a more compact microstructure, as 
observed in iGG-MA and phGG-MA as compared to GG hydro-
gels, has been shown to be more effective in preventing infi l-
tration of endothelial cells and blood vessels. [ 26 ] Therefore, this 
strategy can be used for tailoring the fi nal properties of the GG-
based hydrogels, in order to mimic the functional properties of 
the tissue aimed to regenerate. Also in this work, [ 25 ] the authors 
demonstrated, by following standard tests for assessment of bio-
compatibility safety of medical devices, that the degree of meth-
acrylation of the modifi ed material (i.e., GG-MA) was not cyto-
toxic to cells. Despite the promising physicochemical properties 
of the iGG-MA and phGG-MA hydrogels and non-cytotoxicity, 
no information on the cells encapsulation ability and in vivo 
biocompatibility of the hydrogels has been reported. wileyonlinelibrary.com © 2012 WILEY-VCH Verlag G In this work, our aim was to investigate the long-term in 
vitro stability and screen the biocompatibility of the iGG-MA 
and phGG-MA hydrogels, in vitro and in vivo. Moreover, the 
molecular weight distribution of the GG-MA was determined by 
size exclusion chromatography. Degradation and water uptake 
studies were performed by means of soaking the iGG-MA and 
phGG-MA hydrogels in a phosphate buffered saline solution 
(pH 7.4, 37  ° C) for times ranging from 1 up to 90 days. The 
ability of the iGG-MA and phGG-MA hydrogels for cells encap-
sulation was evaluated by culturing the well-established immor-
talized mouse lung fi broblast cell line and primary human 
IVD cells within the hydrogels, for 1 up to 21 days. After each 
culturing time point, calcein-AM staining was performed to 
qualitatively evaluate the cells viability. For the purpose of the 
in vivo study, subcutaneous implantation of the iGG-MA and 
phGG-MA hydrogels in a rat model was performed. After 10 
and 18 days of implantation, the haematoxylin and eosin (H&E) 
stained sections of explants were observed for evaluation of bio-
compatibility and cell infi ltration into the hydrogels implants. 
 2. Results 
 2.1. Characterization of the Methacrylated Gellan Gum 
Hydrogels 
 To further investigate the chemical modifi cation of low acyl 
gellan gum (GG) with glycidyl methacrylate (GMA), the molec-
ular weight distribution of resulting methacrylated gellan gum 
(GG-MA) powder was determined by size exclusion chroma-
tography (SEC).  Table  1 shows that the molecular weight (Mw) 
of GG-MA is slightly lower as compared to GG. Additionally, 
the calculation of the polydispersity index (Mw/Mn) reveals 
that both polymers present a uniform distribution of molecular 
weight. 
 The long-term stability of the ionic- (iGG-MA) and photo-
crosslinked (phGG-MA) methacrylated gellan gum hydrogels 
was evaluated by soaking the hydrogels in a PBS solution (pH 
7.4 at 37  ° C) up to 90 days.  Figure  1 shows the weight loss and 
water uptake profi le of iGG-MA and phGG-MA hydrogels. No 
signifi cant weight loss was observed among the hydrogels until 
90 days (Figure  1 A). Despite it was observed an increase in 
weight loss of iGG-MA hydrogels after 90 days, as compared 
to phGG-MA hydrogels, this value is not statistically signifi cant 
( p  > 0.05). Regarding the water uptake ability of the hydrogels, 
although the results suggest that the iGG-MA hydrogels were 
able to retain more water as compared to phGG-MA hydro-
gels until 60 days (Figure  1 B), statistical analysis has shown 
that this difference is not signifi cant. Additionally, the higher 
water content shown by the phGG-MA hydrogels as compared 
to iGG-MA hydrogels after 90 days is not statistically signifi cant 
( p  > 0.05). 
 2.2. Cell-Laden Hydrogels 
 In order to evaluate the biocompatibility of iGG-MA and phGG-
MA hydrogels in vitro, different cell types were encapsulated mbH & Co. KGaA, Weinheim Adv. Healthcare Mater. 2012, 
DOI: 10.1002/adhm.201200256
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 Table  1.  Molecular weight determination of gellan gum (GG) and 
methacrylated gellan gum (GG-MA) measured by size exclusion 
chromatography. 
Sample Mw [kDa] Mn [kDa] Polydispersity index [Mw/Mn]
GG 71.1 63.9 1.11
GG-MA 70.6 62.4 1.13within the hydrogels and cultured up to 21 days. Cells viability 
was visualized by means of staining the cell-laden iGG-MA 
and phGG-MA hydrogels with calcein-AM after each culturing 
time.  Figure  2 shows that mouse lung fi broblast (L929) cells 
remained viable until 21 days of culturing, as observed by 
the green fl uorescence, and where generally well dispersed 
within the matrices of both hydrogels.  Figure  3 also revealed 
that the hydrogels can support the viability of primary human 
IVD (hIVD) cells. Human IVD cells were also homogeneously 
distributed within the iGG-MA and phGG-MA hydrogels. 
Moreover, it was observed that the hIVD cells maintained its 
round-shape morphology during culturing time. © 2012 WILEY-VCH Verlag 
 Figure  1 .  Weight loss (A) and water uptake (B) of ionic- (iGG-MA) and 
photo-crosslinked (phGG-MA) methacrylated gellan gum hydrogel discs. 
All samples were immersed in PBS (pH 7.4; 37  ° C and 60 rpm) for times 
ranging from 1 up to 90 days. Values are expressed as mean  ± SD ( n  = 9). 
 Figure  2 .  Fluorescence microscopy images of the L929 cells encapsu-
lated within the ionic- and photo-crosslinked methacrylated gellan gum 
(GG-MA) hydrogels and cultured from 1 up to 21 days. The cells were 
stained with calcein-AM (green fl uorescence), prior to observation. 
Adv. Healthcare Mater. 2012, 
DOI: 10.1002/adhm.201200256 2.3. In Vivo Biocompatibility Assessment 
 After subcutaneous implantation in a rat model, the iGG-MA 
and phGG-MA implants were retrieved and processed for his-
tological analysis. No signs of infection, necrosis or calcifi ca-
tion were detected at the implantation sites, for all implants 
after 10 and 18 days of implantation.  Table  2 summarizes the 
semi-quantitative analysis of the infl ammatory cells within the 
iGG-MA and phGG-MA hydrogel explants. At day 10, both 
materials showed a moderate infi ltration of granulocytes and 
macrophages. It was also observed a minor number of non-
phagocytic cells and a moderate amount of fi broblasts around 
the hydrogel implants. At day 18, scaffolds showed a minor 
infi ltration of granulocytes, macrophages and non-phagocytic 3wileyonlinelibrary.comGmbH & Co. KGaA, Weinheim
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 Table  2.  Cellular response to ionic- (iGG-MA) and photo-crosslinked 
(phGG-MA) hydrogel implants. Cells were scored from absent (−) to 
abundantly present ( + + + ). 
Implantation 
time [days]
Implant 
material
PMNs a) Phagocytic 
cells b) 
Non-phagocytic 
cells c) 
Fibroblasts
10 iGG-MA  + +  + +  +  + + 
phGG-MA  + +  + +  +  + + 
18 iGG-MA  +  +  +  + 
phGG-MA  +  +  +  + 
 a) PMNs  = polymorphic nuclear cells, i.e., granulocytes; b) Phagocytic cells include 
macrophages and monocyte-derived giant cells; c) Non-phagocytic cells include 
lymphocytes, plasma cells and mast cells. 
 Figure  3 .  Fluorescence microscopy images of the hIVD cells encapsu-
lated within the ionic- and photo-crosslinked methacrylated gellan gum 
(GG-MA) hydrogels and cultured from 1 up to 21 days. The cells were 
stained with calcein-AM (green fl uorescence), prior to observation. cells. A small infi ltration of fi broblasts was also detected. The 
absolute numbers of polymorphic nuclear cells (PMNs) and 
non-phagocytic cells are lower as compared to phagocytic cells. 
 Figure 4 shows the light microscopy photographs of the the 
iGG-MA and phGG-MA explants after 10 days of subcutaneous 
implantation, which were stained with haematoxylin & eosin 
(H&E). A connective thin fi brous tissue was observed sur-
rounding both implanted iGG-MA and phGG-MA hydrogels, 
which assumed the form of fi bres. The central part presented 
void spaces and no cells were observed within both iGG-MA 
and phGG-MA hydrogels. At high magnifi cation, H&E images 
clearly showed newly formed connective tissue septa sur-
rounding the periphery of the hydrogels (black arrows). No 
infl ammatory cells such as macrophages and foreign body giant 4 wileyonlinelibrary.com © 2012 WILEY-VCH Verlag Gmcells were observed. Similar observations for both hydrogels 
after 18 days of implantation were found, i.e., no infl ammatory 
cells were present in the implants ( Figure  5 ). 
 3. Discussion 
 Photo-polymerization of hydrogels is being investigated due to 
the possibility of tailoring the physicochemical properties of bio-
materials namely, degradation or resorption rate, swelling, per-
meability to cells/molecules, and mechanical properties. [ 19 , 27 , 28 ] 
As aforementioned, our group has been proposing the use of 
ionic-crosslinked low acyl gellan gum (GG) hydrogels for tissue 
engineering scaffolding applications. Photo-polymerization 
may be used as a reliable strategy for tuning the properties of 
materials. Thus, we were encouraged to chemically modify the 
low acyl GG with glycidyl methacrylate in order to develop a 
photo-polymerizable hydrogel that can best resemble the phys-
ical characteristics of NP tissue. Previously, we have shown 
that photo- (phGG-MA) and ionic-crosslinked (iGG-MA) meth-
acrylated gellan gum hydrogels present a storage modulus at 
1 Hz of 122.8  ± 8.3 kPa and 89.5  ± 7.4 kPa, respectively. [ 25 ] The 
GG-MA hydrogels present improved mechanical performance 
as compared to that of GG hydrogels (56.2  ± 1.4 kPa) which 
results from a higher crosslinking density. In fact, rheological 
analysis has been shown that native human NP presents a 
shear modulus of 7–20 kPa that corresponds to a Young’s mod-
ulus of 20–60 kPa. [ 29 , 30 ] These values, which are similar to those 
obtained for GG hydrogels, were however obtained  post mortem 
and they may not translate the real native NP properties. [ 31 ] The 
sheep model is often used to perform IVD mechanical studies 
since it is believed to be one of the animal models that best 
resemble the human IVD. [ 32 ] Dynamic compression studies 
revealed that NP sheep has a storage modulus of 64  ± 28 kPa, [ 29 ] 
which is lower as compared to the phGG-MA and iGG-MA 
hydrogels. 
 In this study, SEC analysis revealed that GG-MA has a molec-
ular weight slightly lower than GG. From results, we can state 
that the methacrylation of GG did not signifi cantly change its 
molecular weight and polydispersity index. It should be high-
lighted that methacrylation of GG improved the water-solubility 
of the polymer, and contrarily to GG, homogeneous dissolution 
of GG-MA powders can be performed at room temperature. bH & Co. KGaA, Weinheim Adv. Healthcare Mater. 2012, 
DOI: 10.1002/adhm.201200256
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 Figure  4 .  Light microscopy images of ionic- (iGG-MA) and photo-crosslinked (phGG-MA) 
methacrylated gellan gum hydrogel explants sections stained with H&E, after 10 days of sub-
cutaneous implantation. Arrows indicate the newly formed connective tissue septa surrounding 
the periphery of the hydrogels.  Following the initial study [ 25 ] on the gellan gum-based 
hydrogels stability, the iGG-MA and phGG-MA hydrogels were 
selected as the most promising biomaterials for NP regen-
eration. The long-term stability studies of the iGG-MA and 
phGG-MA hydrogels showed that no signifi cant weight loss 
was observed among the hydrogels until 60 days, but a slight 
increase in weight loss of iGG-MA hydrogels as compared to 
phGG-MA hydrogels, although not statistically signifi cant, was 
observed after 90 days. The water uptake study revealed that 
the phGG-MA hydrogels were able to swell less as compared 
to iGG-MA hydrogels until 60 days of soaking. Although the 
differences were not statistically signifi cant, these results can 
be attributed to a higher crosslinking density of the phGG-MA 
hydrogels, consistent with a tighter matrix which thus is less 
able to retain water. After 90 days, the phGG-MA hydrogels 
presented higher water content as compared to that of iGG-MA © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinhe
 Figure  5 .  Light microscopy images of ionic- (iGG-MA) and photo-crosslinked (phGG-MA) 
methacrylated gellan gum hydrogel explants sections stained with H&E, after 18 days of sub-
cutaneous implantation. Arrows point to the newly formed connective tissue septa surrounding 
the periphery of the hydrogels. 
Adv. Healthcare Mater. 2012, 
DOI: 10.1002/adhm.201200256hydrogels, again not statistically signifi cant, 
which can be attributed to the increase in the 
weight loss of iGG-MA hydrogels. This result 
is particularly interesting since we are able to 
tune both hydrogels’ water retention and deg-
radation rate by means of playing with the 
method of crosslinking of the GG-MA bioma-
terial. Actually, the developed iGG-MA and 
phGG-MA hydrogels presented a better long-
term stability as compared to other reported 
biomaterials [ 20 ] with promising application 
in NP tissue engineering. Degradation and 
swelling assays need to be performed for 
longer periods of incubation, as well as in 
enzymatic medium, in order to better charac-
terize the in vitro stability of the iGG-MA and 
phGG-MA hydrogels. 
 Tissue engineering of degenerated NP 
demands for a hydrogel substitute that can 
mimic its native avascular structure. Thus, 
non- or anti-angiogenic hydrogels are needed 
for this particular application, since ang-iogenesis is also one of the factors promoting IVD degenera-
tion and pain. [ 33 ] In previous work, [ 26 ] the angiogenic response 
of iGG-MA and phGG-MA hydrogels was investigated by per-
forming the chorioallantoic membrane (CAM) assay, a well-
established model to investigate angiogenesis in vivo. [ 34 , 35 ] 
Results have shown that the iGG-MA and phGG-MA hydrogels 
were well tolerated, adhered fi rmly to the CAM and did not elicit 
any infl ammatory reaction. More importantly, the iGG-MA and 
phGG-MA hydrogels were able to control endothelial cells infi l-
tration and blood vessels invasion during the period of implan-
tation, properties that are a must when designing an adequate 
NP substitute. 
 Photo-polymerized hydrogels are also appealing from both 
surgical and tissue engineering point of view, as it can be 
applied at defect area using minimally invasive procedures, 
while simultaneously enable cells encapsulation and  in situ gela-tion to occur. [ 27 ] But, photo-polymerization 
frequently involves use of photo-initiators, 
UV light, and increase in gels temperature 
during the gelation process, and thus the 
developed hydrogels cannot be utilized in 
tissue engineering because of the lack of 
cyto- and bio-compatibility. 
 The in vitro and in vivo biocompatibility of 
the developed iGG-MA and phGG-MA hydro-
gels was evaluated following well-established 
protocols. [ 36–38 ] In the current work, we have 
fi rstly investigated the ability of the GG-MA 
biomaterial towards cells encapsulation 
using two distinct processes, i.e., ionic- and 
photo-crosslinking. Both methods allowed 
us to homogeneously seed the L929 cells and 
hIVD cells throughout the gels and to form 
stable hydrogels within seconds to few min-
utes. The viability assay showed that iGG-MA 
and phGG-MA hydrogels supported cells 
functions up to 21 days of culturing. Thus, 5wileyonlinelibrary.comim
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6the present data showed that the use of MBF photo-initiator 
and photo-polymerization conditions, i.e., UV light (366 nm) 
and gelation time (6 minutes) did not affect cells viability. It 
has been reported that potential cellular damage can occur 
due to UV radiation, but it is dependent on cell type, time of 
exposure and type/concentration of the photo-initiator. [ 39–41 ] In 
future work, we will investigate possible cellular DNA damage, 
in short- and long-term, after exposure to UV light in these 
conditions. In order to investigate the cellular response to the 
iGG-MA and phGG-MA hydrogels after subcutaneous implan-
tation for 10 and 18 days, masked microscopic examinations 
were performed by means of H&E staining for infl ammatory 
cells. [ 42 ] After 10 days of implantation, both implant materials 
showed a moderate infi ltration of granulocytes and macro-
phages, minor of non-phagocytic cells and a moderate amount 
of fi broblasts around the hydrogel implants. By its turn, no 
infi ltration of granulocytes, macrophages and non-phagocytic 
cells was observed after 18 days of implantation. Thus, the in 
vitro and in vivo data demonstrated that both hydrogels present 
a good tissue compatibility and non-toxicity. 
 Although this study was focused on screening the long-
term stability, and in vitro and in vivo biocompatibility of both 
iGG-MA and phGG-MA hydrogels, future work will investigate 
the effect of environmental stimuli (e.g., growth factor supple-
mentation - TGF-beta 3), on maintenance of phenotypic ECM 
components in cell-laden hydrogels. In addition, long-term 
in vivo experiments need to be performed in order to further 
determine degradability rate of the developed hydrogels. 
 4. Conclusions 
 In this work, we demonstrate that photo-polymerization of 
methacrylated gellan gum (GG-MA) allowed improvement of 
both the stability of the hydrogels and to tune swelling. More-
over, the ionic- (iGG-MA) and photo-crosslinked (phGG-MA) 
hydrogels were shown to be effective on supporting cells’ encap-
sulation and viability up to 21 days of culturing. The in vivo bio-
compatibility screening showed that iGG-MA and phGG-MA 
hydrogels do not elicit any deleterious effect or infl ammatory 
reaction. Thus, this study reveals that the well-tolerated and 
non-toxic ionic- and photo-crosslinked methacrylated gellan 
gum hydrogels possess promising physicochemical and biolog-
ical properties for fi nding application as viable NP substitutes. 
 5. Experimental Section 
 Materials : Methacrylated gellan gum (GG-MA) powder was produced 
by means of chemical modifi cation of low-acyl gellan gum (LA-GG, 
Gelzan CM; Sigma-Aldrich Co., USA). Glycidyl methacrylate (GMA, 97%) 
and methyl benzoylformate photo-initiator (MBF, 98%) were purchased 
from Sigma-Aldrich Co. (USA). All reagents were obtained from Sigma-
Aldrich Co. (USA), unless otherwise indicated. 
 Synthesis of GG-MA Powders and Preparation of the Ionic- and Photo-
Crosslinked GG-MA Hydrogel Discs : The methacrylation of gellan gum 
was performed by reaction of LA-GG with GMA at 20-fold molar excess 
in respect to the repeating unit of LA-GG, as previously described 
by Silva-Correia et al . [ 25 ] Briefl y, a solution of LA-GG at 1% (w/v) fi nal 
concentration was prepared in distilled water at room temperature 
and under vigorous agitation. The LA-GG solution was heated to wileyonlinelibrary.com © 2012 WILEY-VCH Verlag G90  ° C in a water bath in order to obtain a homogeneous dispersion. 
The LA-GG solution was allowed to cool down until reaching room 
temperature and an appropriate amount of GMA was added. The pH 
of the reaction mixture was automatically adjusted to 8.5 with 1 M 
sodium hydroxide (NaOH; Panreac Química SAU, Spain) by means 
of using an automatic pump (Fusion 200; Chemyx Inc., USA). Then, 
the GG-MA was precipitated with cold acetone (0.5 volumes; Panreac 
Química SAU, Spain) and the excess of GMA and acetone eliminated 
off by dialysis (cellulose membrane, MW cut-off 12 kDa; Sigma, USA) 
for 7 days. Finally, the purifi ed GG-MA dialyzed solution was frozen at 
−80  ° C and the GG-MA powders were obtained by freeze-drying (Cryodos 
−80; Telstar, Spain). 
 The ionic- (iGG-MA) and photo-crosslinked (phGG-MA) methacrylated 
gellan gum hydrogel discs, possessing a diameter of 7 mm and height 
of approximately 4 mm, were obtained by dissolving the GG-MA powder 
in distilled water at a fi nal concentration of 2% (w/v), under vigorous 
agitation and at room temperature. For the preparation of iGG-MA 
hydrogel discs, 150  μ L of the 2% (w/v) GG-MA aqueous solution were 
transferred to a silicone mould and gelation of the gels was induced 
by immersion in PBS (pH 7.4) for 30 minutes. The phGG-MA hydrogel 
discs were obtained by means of adding 0.1% (w/v) photo-initiator 
MBF to the 2% (w/v) GG-MA aqueous solution. Then, 150  μ L of the 
mixture were transferred to a silicone mould and the hydrogel discs 
were obtained by exposing the gels to ultraviolet light (366 nm, UV lamp 
Triwood 6/36; Bresciani srl., Italy) for the period of 6 minutes. Finally, 
the phGG-MA hydrogel discs were further equilibrated in PBS (pH 7.4) 
for 30 minutes. 
 For the purpose of the in vitro cell encapsulation and in vivo studies, 
GG-MA powders were sterilized under an ethylene oxide gas atmosphere, 
and the iGG-MA and phGG-MA hydrogel discs were prepared in sterile 
conditions, i.e., using sterile materials and reagents inside a laminar-
fl ow hood (BH-EN 2004-D; Faster, UK). 
 Molecular Weight Determination : Weight-average molecular weights 
( M W ) and number-average molecular weights ( M n ) were determined 
by size exclusion chromatography (SEC) with triple detection (Viscotek 
Triple Detector Array–TDA 305; Malvern, UK), using OmniSec software 
(Viscotek, version 4.6.1.354; Malvern, UK). A Viscotek VE 1122 solvent 
delivery system was connected to one Viscotek AGuard 50  × 6.0 mm 
pre-column, one Viscotek A2000 column and one Viscotek A2500 
column (300  × 7.8 mm). A Viscotek TDA 305 triple detector array was 
used, including right-angle light scattering (RALS), refractive index (RI) 
and Viscosimetry detectors. A solution of NaN 3 at 0.02% (w/v) was used 
as eluent and the samples were eluted at a fl ow rate of 1 mL·min  − 1 at 
60 ° C. Polymer concentration was 1 g·L  − 1 and polymer solutions were 
fi ltered through 0.45  μ m pore size membranes before injection. 
 Water Uptake and Weight loss Studies : The iGG-MA and phGG-MA 
hydrogels discs swelling ability and weight loss were investigated by 
means of soaking the hydrogel discs in PBS (pH 7.4), from 1 up to 
90 days. The study was carried out at 37  ° C and under constant agitation 
(60 rpm). After each time point, the water uptake and weight loss of 
the hydrogels were calculated as previously described elsewhere. [ 25 ] 
The studies were performed using a minimum of three samples per 
experimental condition ( n  = 9) and values are expressed as mean  ± SD. 
Statistical analysis (GraphPad Prism; GraphPad Software, San Diego, 
USA) was performed using a Two-way analysis of variance followed 
by Bonferroni  post -test with a minimum confi dence level of 0.05 for 
statistical signifi cance. 
 In Vitro Cells Encapsulation Study: L929 Cells Encapsulation and 
Culturing : The ability of ionic- and photo-crosslinked GG-MA hydrogels 
for encapsulating cells in mild conditions (room temperature) was 
evaluated using the well-established immortalized mouse lung fi broblast 
cell line (L929 cells), purchased from European Collection of Cell Cultures 
(ECACC, UK). L929 cells were grown as a monolayer in Dulbecco’s 
modifi ed Eagle’s medium (DMEM; Sigma, USA) supplemented with 10% 
foetal bovine serum (FBS; Biochrom, Germany) and 1% of an antibiotic-
antimycotic mixture (Invitrogen, USA) containing 10 000 units·mL  − 1 
penicillin G sodium, 10 000  μ g·mL  − 1 streptomycin sulphate and 
25  μ g·mL  − 1 amphotericin B as Fungizone Antimycotic in 0.85% saline. mbH & Co. KGaA, Weinheim Adv. Healthcare Mater. 2012, 
DOI: 10.1002/adhm.201200256
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5% CO 2 , and the medium changed every two days. A chemical method 
using trypsin (0.25% trypsin/EDTA solution, Sigma, USA) was used to 
promote cell detachment from confl uent culture fl asks. Afterwards, a 
diluted cell suspension was prepared and centrifuged at 1200 rpm for 
5 minutes. The medium was completely aspirated and the cell pellet 
was re-suspended in the respective hydrogel solution to yield a fi nal 
concentration of 2.5  × 10 6 cells·mL  − 1 . Solutions at 2% (w/v) made of 
GG-MA and GG-MA with 0.1% (w/v) MBF were prepared under sterile 
conditions, prior cells encapsulation. Cell-laden gels were centrifuged at 
600 rpm for 3 minutes to allow homogenization of cells. Then, L929 cells-
laden hydrogels (200  μ L/disc) were transferred to silicone moulds to 
produce discs with a diameter of 7 mm. For obtaining cell-laden iGG-MA 
hydrogels, the iGG-MA gel with encapsulated L929 cells (5  × 10 5 cells/
disc) was then immersed in PBS solution for crosslinking. For producing 
cell-laden phGG-MA hydrogels, the GG-MA gels containing MBF at 0.1% 
(w/v) with L929 cells were exposed to UV light for 6 minutes (366 nm; 
UV lamp Triwood 6/36, Bresciani srl., Italy), and then equilibrated in PBS 
solution as previously described in section 2.2. Afterwards, the cell-laden 
hydrogels were cultured (37  ° C and 5% CO 2 ) for different time periods 
in complete DMEM culture medium. 
 In Vitro Cells Encapsulation Study: Isolation of hIVD Cells and 
Encapsulation : Human intervertebral disc (hIVD) cells were isolated using 
an enzymatic digestion-based method from herniated tissue obtained 
from a female patient (age 36) submitted to surgery. The human 
biological tissue was collected in accordance to the Ethics Committee at 
the Centro Hospitalar Póvoa de Varzim and an informed signed consent 
was obtained from the patient. Briefl y, the tissue was washed several 
times with PBS containing 1% (v/v) antibiotic-antimycotic mixture in 
order to completely remove blood and other bodily contaminants. The 
extracted tissue was separated from obvious dense annulus-like tissue 
and cut in small pieces in order to increase the effi ciency of digestion. 
Human tissue digestion was performed by incubation at 37  ° C 
in a humidifi ed atmosphere of 5% CO 2 for 24 hours in 20 mL of cell 
medium Dulbecco’s modifi ed Eagle’s medium:Nutrient mixture F12 1:1 
(DMEM:F12; Invitrogen, USA) containing 0.3% (w/v) collagenase type 
II (Sigma-Aldrich Co., USA) and supplemented with 10% (v/v) FBS, 1% 
(v/v) of an antibiotic-antimycotic mixture containing 10 000 units·mL  − 1 
penicillin G sodium, 10 000  μ g·mL  − 1 streptomycin sulphate and 
25  μ g · mL  − 1 amphotericin B as Fungizone Antimycotic in 0.85% saline. 
After digestion, the cells were separated from the remaining tissue debris 
by using a cell strainer (100  μ m). The isolated hIVD cells were expanded 
in DMEM:F12 (1:1) medium supplemented with 10% (v/v) FBS and 1% 
(v/v) of an antibiotic-antimycotic mixture in standard culture conditions 
until reaching confl uence. The medium was changed every three days. 
The isolated hIVD cells were used for encapsulation within the iGG-MA 
and phGG-MA hydrogel discs at passage 4 (P4). Confl uent cells were 
detached from the culture fl asks using 0.25% trypsin/EDTA solution. 
Afterwards, a diluted cell suspension was prepared and centrifuged 
at 1200 rpm for 5 minutes. Prior encapsulation of hIVD cells in the 
hydrogels, the medium was completely aspirated and the cell pellet was 
re-suspended in the respective hydrogel solution, i.e., GG-MA or MBF-
containing GG-MA solution. The cell-loaded hydrogels were produced in 
cylindrical silicone moulds with 6 mm diameter by using 2  × 10 5 cells 
per 100  μ L of hydrogel. The hydrogel discs with encapsulated hIVD 
cells were either ionic- (in PBS solution) or photo-crosslinked (UV 
light at 366 nm for 6 min). Afterwards, hIVD cells/hydrogel discs were 
cultured in complete DMEM:F12 culture medium at 37  ° C and in 5% 
CO 2 atmosphere for different periods of culturing. 
 In Vitro Cells Encapsulation Study: Calcein-AM Staining : Cell viability 
was assessed using calcein-AM staining, after 1, 3, 7, 14, and 21 days 
of culturing. Briefl y, a calcein-AM (Molecular Probes, USA) solution of 
1/1000 was prepared in serum-free culture medium without phenol red. 
The cells-laden iGG-MA and phGG-MA hydrogels were washed with PBS 
once, transferred to a 24-well tissue-culture polystyrene (TCPS) plate and 
incubated in the calcein-AM solution for 15 minutes at 37  ° C and with 
5% CO 2 . The specimens were washed in sterile PBS and observed under 
fl uorescence microscopy using an Axio Imager.Z1m light microscope © 2012 WILEY-VCH Verlag GAdv. Healthcare Mater. 2012, 
DOI: 10.1002/adhm.201200256(Zeiss, Germany) with an attached digital camera AxioCam MRm (Zeiss, 
Germany) connected to the AxioVision image processing software 
(Zeiss, Germany). All experiments were repeated three times using a 
minimum of two samples per experimental condition. 
 In Vivo Study: Subcutaneous Implantation : The protocol for the in 
vivo study was performed as approved by the Institutional Animal 
Care Committee of Padua University. Adult female Lewis rats (Charles 
River Laboratories), weighing 150–200 g, were subjected to the surgical 
procedures under halothane anesthesia and aseptic conditions. Ionic- 
and photo-crosslinked gellan gum hydrogels were implanted in the 
abdominal area. Throughout small (0.3 cm) skin incisions, the iGG-MA 
and phGG-MA hydrogels were implanted in a subcutaneous (s.c.) 
pocket above the abdominal fascia. Skin incisions were closed with 
nylon 5 mm stitch. No anticoagulants and prophylactic antibiotic were 
administered to animals before or after surgery. All surgical procedures 
were performed in the same way by a single surgeon. The animals were 
fed an unrestricted standard diet. After 10 and 18 days of implantation, 
the animals were sacrifi ced by an overdose of gaseous anesthetic, and 
the implants retrieved for further characterization. 
 In Vivo Study: Haematoxylin & Eosin (H&E) Staining : Explants were 
transferred to a fi xative solution for 4 hours and then immersed in PBS 
solution with 0.02% sodium azide. Afterwards, the specimens were 
stored at 4  ° C until the fi nal preparation. The explants were dehydrated 
in graded ethanol solutions (70–99.5%), cleared in xylene, and then 
embedded in paraffi n. [ 43 ] Sections of the explants (5  μ m) were cut on 
a standard microtome, and routine light microscopy examination was 
performed after staining with H&E for evaluation of biocompatibility and 
cell infi ltration into the implants. 
 In Vivo Study: Quantitative Analysis of Cells : In order to analyze the 
cellular response to biomaterials, masked microscopic examinations were 
performed by means of H&E staining for infl ammatory cells. [ 42 ] Briefl y, 
two researchers analyzed in a masked fashion at least 3 slides for each 
experiment by light microscopy, using 20× as the initial magnifi cation. 
Each slide contained 3 sections of specimen, and 5 fi elds of 322 mm 2 
each were analyzed for each tissue section. Experiments were performed 
at least three times and values are expressed as mean  ± SD. 
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